Registration for a live webinar on 'Precision medicine treatment for anticancer drug resistance' is now open.
See webinar detailsWe noted you are experiencing viewing problems
-
Check with your IT department that JWPlatform, JWPlayer and Amazon AWS & CloudFront are not being blocked by your network. The relevant domains are *.jwplatform.com, *.jwpsrv.com, *.jwpcdn.com, jwpltx.com, jwpsrv.a.ssl.fastly.net, *.amazonaws.com and *.cloudfront.net. The relevant ports are 80 and 443.
-
Check the following talk links to see which ones work correctly:
Auto Mode
HTTP Progressive Download Send us your results from the above test links at access@hstalks.com and we will contact you with further advice on troubleshooting your viewing problems. -
No luck yet? More tips for troubleshooting viewing issues
-
Contact HST Support access@hstalks.com
-
Please review our troubleshooting guide for tips and advice on resolving your viewing problems.
-
For additional help, please don't hesitate to contact HST support access@hstalks.com
We hope you have enjoyed this limited-length demo
This is a limited length demo talk; you may
login or
review methods of
obtaining more access.
Printable Handouts
Navigable Slide Index
- Introduction
- The human microbiome
- Gastrointestinal microbiome
- 16S ribosomal RNA
- Analysis of bacterial composition using 16S rRNA
- Quantification of bacterial groups using 16S rRNA
- What about metabolic activity?
- Physiological roles of intestinal microbiota
- Mammalian mucosal surfaces
- Existing with an enormous bacterial burden
- Microbial challenge at wet mucosal epithelia
- The anatomy of the mucosal barrier
- The human gastrointestinal tract
- Paneth cell granules contents
- Activity of antimicrobial effectors
- Paneth cells' response to bacterial products
- IFN-gamma triggers Paneth cell degranulation
- Detection of HD-5 and HD-6 mRNA in Paneth cells
- Activated crypt defensins in germ-free mice
- RegIII-gamma expression is triggered by bacteria
- Intestinal antimicrobial peptides
- Structure of defensins
- Functions of defensins
- Processing of defensins
- MMP7 KO mice: a model for defensin deficiency
- A HD5 (DEFA5) transgenic mouse model
- DEFA5 transgenic mice are resistant to infection
- HD6 transgenic mouse model
- Salmonella-challenged HD6 mice
- HD6 self assembles into nanonets
- Paneth cells express CD24
- Regulation of PC RegIII-gamma expression
- PC NOD2 and bacterial homeostasis
- NOD2 is required for crypt defensin expression
- LRRK2 and Nod2 regulate lysozyme sorting
- Total bacteria quantification: HD5 and MMP7 mice
- Microbial community comparisons
- FISH analysis of SFB from mouse terminal ileum
- SFB (Candidatus arthromitis)
- LPL from HD5 mice lack IL17 expression
- Paneth cells defensins regulate the microbiota
- CD patients have reduced defensins expression
- Defensins, microbiota and intestinal homeostasis
- Paneth cells and intestinal homeostasis regulation
- Paneth cell antimicrobials maintain homeostasis
- Paneth cell abnormalities and disease
- Homeostasis and dysbiosis of Paneth cells
- Acknowledgements
Topics Covered
- The human microbiome
- 16S ribosomal RNA
- Physiological roles of the intestinal microbiota
- Mammalian mucosal surfaces
- Paneth cells
- Intestinal antimicrobial peptides
- The defensins: animal models
- Defensins, regulation of the microbiota and implications for intestinal homeostasis
- Paneth cells and the regulation of intestinal homeostasis
- Diseases associated with Paneth cell abnormalities
Links
Series:
Categories:
Therapeutic Areas:
Talk Citation
Salzman, N. (2017, February 27). Paneth cells, antimicrobial peptides and the regulation of the intestinal microbiota [Video file]. In The Biomedical & Life Sciences Collection, Henry Stewart Talks. Retrieved December 22, 2024, from https://doi.org/10.69645/GQGN8958.Export Citation (RIS)
Publication History
Financial Disclosures
- Dr. Nita Salzman has not informed HSTalks of any commercial/financial relationship that it is appropriate to disclose.
Paneth cells, antimicrobial peptides and the regulation of the intestinal microbiota
A selection of talks on Clinical Practice
Transcript
Please wait while the transcript is being prepared...
0:00
My name is Dr. Nita Salzman.
I am a Professor of Pediatrics
in the Division of Gastroenterology
at The Medical College
of Wisconsin.
The title of my presentation today
is "Paneth Cells,
Antimicrobial Peptides,
and the Regulation
of the Intestinal Microbiota".
0:18
Humans and other mammals
are colonized
by a vast number
of diverse microorganisms
collectively known
as the microbiome.
The human microbiome is defined as,
"The totality of microorganisms
and their collective
genetic material
present in
or on the human body."
The human microbiome,
while predominantly bacterial,
is also comprised of viruses,
archaea, and eukaryotic microbes.
Each body site harbors
a distinct microbiome.
The GI tract is the largest
mammalian mucosal surface
and contains the majority
of the total human microbiome.
The majority
of the bacteria comprising
the microbiota resist culturing
by conventional techniques.
0:59
The GI tract is the largest
mammalian mucosal surface.
And this mucosal surface
is highly colonized
by a diverse microbial ecosystem.
If you consider the GI tract
as a tube
that starts at the mouth
and ends at the rectum,
the red dots depicted
in this cartoon
represent bacterial colonization.
Mammals including humans
are colonized
by vast numbers of microbes,
predominantly bacteria.
And the majority
of these colonizers
are in the GI tract.
At current estimates
between 500 and 1,000
different bacterial species
can be found in the GI tract.
Anaerobic bacteria outnumber
aerobic bacteria by 10-100 fold.
Bacteria in the GI tract
are comprised
of transient organisms
and indigenous organisms.
And currently,
there is no accepted way
of distinguishing these groups.
The overall dominant phyla
in the small and large bowel
include the Bacteroides
which are Gram-negative,
and the Firmicutes,
which are Gram-positive.
The most abundant members
of the Firmicutes phylum
are clostridial species.
The density of colonization
as well as the specific composition
and diversity of colonization
is dependant on site
and specific
intestinal microenvironment,
including pH, oxygen environment,
nutrient environment,
and likely several factors
that are yet undetermined.
The mouth,
which is generally at a neutral pH,
is highly colonized.
The esophagus has a low level
of resident microbiota.
While the stomach has somewhat
increased bacterial abundance.
The proximal small intestine
reflects the bacterial burden
of the stomach,
at about 10 to the 4th cfu/ml.
But the bacterial burden increases,
as you move distally,
ultimately reaching 10 to the 8th
cfu/ml in the terminal ileum.
At the junction,
between the terminal ileum
and the large intestine,
there is an abrupt change
in bacterial abundance,
with the highest abundance
of bacteria
in the large colon at approximately
10 to the 12th cfu/ml.
Although the bacterial composition
are similar at the phylum level,
there are significant differences
between the small
and large intestine,
with respect
to both bacterial diversity
and relative abundance
of specific bacterial taxa.
Hide